Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy

Completed

Conditions studied: Uterine Cancer, Cervical Cancer, Endometrial Cancer

In brief

The goal of this clinical research study is to use CT scans to find any changes in position of the vagina and pelvic lymph node areas during the course of IMRT radiation therapy. Treatment can then be adjusted in order to "spare" as much normal tissue as possible during radiation therapy. Another goal is to study the side effects of IMRT radiation therapy.

Key facts

Study ID

NCT00508703

Run by

M.D. Anderson Cancer Center

People needed

24

Starts

2003-03-05

Expected to finish

2017-09-08

Last updated by the study team

2017-09-12

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients who have been treated with a hysterectomy for carcinoma of the uterine cervix or endometrium who require post-operative radiation or chemoradiation therapy because of positive pelvic lymph nodes or other high-risk local findings.
• Patients must have no evidence of metastatic disease outside of the pelvis.
• Patients must have a Karnofsky Performance Status of >60.
• The patient must be able to understand the protocol and sign a study-specific informed consent. .

You may not qualify if…

• Karnofsky Performance Status < 60.
• Patients with para-aortic nodal disease or who require extended field radiotherapy beyond the pelvis.
• Obese patients who exceed the size limits of hte treatment table or CT scanner.
• Mental status changes or bladder control problems that make the patient unable to comply with bladder-filling instructions.

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.